Rituximab in Patients With ST-elevation Myocardial Infarction
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 372 participants.
Also called NCT05211401
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 372 participants
- Sponsor
- Registry
-
NCT05211401 -
2021-003340-24
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- France
- Registry status
- Recruiting
Technical summary
Registry record NCT05211401. Randomized; double masking; primary purpose treatment. Start 2022-06-01 (actual); primary completion 2027-11 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Rituximab in Patients With ST-elevation Myocardial Infarction
- Acronym
- RITA-MI2
- Condition
- ST Elevated Myocardial Infarction
- Intervention (Drug)
- Active arm 1000 mg
- Intervention (Drug)
- Placebo arm
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Collaborator
- Institut National de la Santé Et de la Recherche Médicale, France
Record details
- Record id
cardio:ct-nct05211401- Content hash
639e6f38367d6e6445b3e97b1c87adde143283635a614393c3b75cfadb751601